Gearhart J M, Seckel C, Vinegar A
ManTech Environmental Technology, Inc., Dayton, Ohio 45431-0009.
Toxicol Appl Pharmacol. 1993 Apr;119(2):258-66. doi: 10.1006/taap.1993.1067.
Mice exposed to various chemicals have been shown to respond by decreasing their core body temperature. To examine what effect such a response might have on the determination of in vivo metabolism, core body temperatures of B6C3F1 mice were recorded with temperature telemetry devices during exposure to chloroform (CHCl3) in a closed, recirculating chamber (100 to 5500 ppm). Significant decreases in body temperature occurred in all mice exposed to greater than 100 ppm CHCl3, with the greatest decrease of 14 degrees C occurring at 5500 ppm. A starting CHCl3 concentration of 4000 ppm had no effect on the 7-ethoxycoumarin O-deethylase (ECOD) activity or P450 levels determined at the end of a 5-hr gas uptake exposure. A physiologically based pharmacokinetic (PB-PK) model was developed to describe the effects of decreased body temperature on the analysis of metabolic data. In vitro ECOD activity as a measure of in vivo P450 metabolism was determined for temperatures ranging from 24 to 40 degrees C. In vitro enzyme activity decreased linearly from a maximum at 37 degrees C to one-third of this activity at 24 degrees C. A linear equation describing this enzymatic activity-temperature correlation was incorporated into the PB-PK model structure to describe decreases in metabolic activity resulting from decreases in core body temperature. In vitro blood/air and tissue/air partition coefficients were determined for CHCl3 at temperatures ranging from 24 to 40 degrees C. All blood/air and tissue/air partitions increased with decreasing temperature, while the tissue/blood partition coefficients calculated from the tissue/air and blood/air partitions decreased with decreasing temperature. Adding these temperature corrections to the model greatly improved the overall fit of the gas uptake curves at all concentrations. Incorporation of a first-order metabolic rate constant was also required to provide an adequate representation of the data at high concentrations. The analysis of gas uptake data by the use of a PB-PK computer model is a very powerful technique for determining in vivo metabolism of many volatile compounds, but the incorporation of significant deviations from a generally used model structure (i.e., Ramsey-Andersen model) to account for shortcomings of the model's ability to adequately analyze a gas uptake data set should be based on data collection when possible.
已表明,暴露于各种化学物质的小鼠会通过降低其核心体温做出反应。为了研究这种反应对体内代谢测定可能产生的影响,在一个封闭的循环 chamber(100至5500 ppm)中,用温度遥测装置记录了B6C3F1小鼠在暴露于氯仿(CHCl3)期间的核心体温。所有暴露于大于100 ppm CHCl3的小鼠体温均显著下降,在5500 ppm时体温下降最大,达14摄氏度。起始CHCl3浓度为4000 ppm对在5小时气体摄取暴露结束时测定的7-乙氧基香豆素O-脱乙基酶(ECOD)活性或P450水平没有影响。开发了一个基于生理学的药代动力学(PB-PK)模型来描述体温下降对代谢数据分析的影响。在24至40摄氏度范围内测定了作为体内P450代谢指标的体外ECOD活性。体外酶活性从37摄氏度时的最大值线性下降至24摄氏度时该活性的三分之一。将描述这种酶活性-温度相关性的线性方程纳入PB-PK模型结构,以描述由于核心体温下降导致的代谢活性降低。在24至40摄氏度范围内测定了CHCl3的体外血/气和组织/气分配系数。所有血/气和组织/气分配系数均随温度降低而增加,而根据组织/气和血/气分配系数计算的组织/血分配系数随温度降低而降低。将这些温度校正添加到模型中大大改善了所有浓度下气体摄取曲线的整体拟合。还需要纳入一级代谢速率常数,以在高浓度下充分表示数据。使用PB-PK计算机模型分析气体摄取数据是确定许多挥发性化合物体内代谢的一种非常强大的技术,但纳入与一般使用的模型结构(即Ramsey-Andersen模型)的显著偏差以弥补模型充分分析气体摄取数据集能力的不足,应尽可能基于数据收集。